Active Ingredient(s): Plerixafor
FDA Approved: * December 15, 2008
Pharm Company: * GENZYME
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Mozobil Overview

Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream. The stem cells are then extracted from the blood and transplanted back to the patient. The drug was developed by AnorMED, which was subsequently bought by Genzyme. Contents 1 Medical uses 2 Contraindications 2.1 Pregnancy and lactation 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 6 Chemist...

Read more Mozobil Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Mozobil Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 20mg/ml
  • Solution: 24mg/1.2ml (20mg/ml), 24mg/2.1ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Mozobil: (2 results)

Sorted by National Drug Code
  • 0024-5862 Mozobil 24 mg/1.2ml Subcutaneous Solution by Sanofi-aventis U.S. LLC
  • 58468-0140 Mozobil 24 mg/1.2ml Subcutaneous Solution by Genzyme Corporation

Other drugs which contain Plerixafor or a similar ingredient: (1 result)

Related Mozobil Topics:

Stem Cell stimulation, Mozobil
I would like to find a doctor who will prescribe this to me for stem cell inhancement for an upcoming dental surgery. Wo...